Health
North America
The Cancer Vaccine Revolution: mRNA Trials Show 78% Recurrence Prevention
Personalised mRNA cancer vaccines show 78% reduction in recurrence in Phase 3 trials, marking a potential paradigm shift in cancer treatment.
Amina Diallo Feb 17, 2026 9 min read Impact: 9.7